Essex Body Sculpture
Calecim Multi Action Cream
Calecim Multi Action Cream
Couldn't load pickup availability
A corrective treatment cream, worn beneath your daily moisturizer, that actively works to lift and firm. Visible benefits can be observed in as little as two weeks, with optimum results in 90 days.
Multi-Action Cream actively targets signs of aging such as skin laxity and sagging, loss of facial contours, as well as diminished skin fullness and volume resulting in thin skin. It works to smoothen out deep wrinkles and deep facial creases such as the nasolabial folds. Discoloration is visibly improved.
UNIQUE, PATENTED STEM CELL TECHNOLOGY
Parent company of CALECIM®Professional, CellResearch Corporation, is a biotechnology company that discovered the presence of stem cells in the umbilical cord lining 10 years ago. It has been found that this is the richest source of epithelial and mesenchymal stem cells from a non-embryonic source. CALECIM® Professional draws on its parent company’s patented stem cell knowledge that is currently also being utilized in US FDA clinical trials for wound-healing.
There are great synergistic benefits from cord lining stem cell research that can be applied to a clinical skincare range that is accessible to everyone.
The active ingredient of CALECIM® Professional is produced in cosmetic-GMP- and ISO-certified laboratories by CellResearchCorp., which owns the patented technology for scientifically derived stem cells from cord-lining tissue.
THE ANTI-AGING STEM CELL AUTHORITY:
STEM CELL THERAPY FOR YOUR SKIN
CALECIM® Professional is a proprietary formula developed from skin regeneration technology. Scientists have discovered how proteins derived from Cord Lining Stem Cells are able to treat symptoms of aging. These proteins direct skin cells to behave in a youthful manner by sending “Youth Messages” that encourage glycoprotein production at multiple layers and restore healthy skin function.
See these in-vitro results for evidence of skin renewal and restoration in skin samples.
Share
